Compare Marsh & McLennan Companies, Inc. (MRSH) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? Marsh & McLennan Companies, Inc. trades at $183.87 (market cap $85.13B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.89B). The key difference: Marsh & McLennan Companies, Inc. is the larger of the two by market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| MRSH | RELX | |
|---|---|---|
Market Cap | $85.13B | $63.89B |
Volume | 2,472,018 | 2,760,502 |
Sector | Financials | Industrials |
52-Week High | $203.85 | $46.80 |
52-Week Low | $157.32 | $27.73 |
Typical Hold Time | 109 Days | — |
Enterprise Value | $105.82B | $75.40B |
Dividend Yield | 2.22% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marsh (MRSH) trades at $177.01, up 0.27% on the day, with a bullish technical signal and strong fundamentals. The company reported revenue of $26.98 billion in 2025, with net income of $4.16 billion and a net margin of 15.41%. Recent earnings have consistently beaten estimates, and the company completed the acquisition of Accel Holdings in October 2026, signaling growth initiatives. Valuation ratios include a P/E of 21.61 and P/S of 3.09, while analyst consensus price target is $202.71.
The outlook for MRSH is positive, supported by earnings beats and strategic acquisitions, but risks include competitive pressures and potential margin compression. Analyst sentiment is mixed with a 'Hold' consensus, suggesting cautious optimism. The stock offers upside to the price target but faces execution risks in integrating acquisitions and maintaining profitability amid economic uncertainties.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
